The Global Cardiovascular Ultrasound System Market to Accelerate Substantially at a Paltry CAGR of 4.79% During the Forecast Period (2022–2027) | DelveInsight

The cardiovascular ultrasound system market is expected to show positive growth due to several factors, including an increase in the geriatric population, an increase in the incidence of cardiovascular diseases, an increase in sedentary lifestyles, and an increase in regulatory approvals for the cardiovascular ultrasound system.

New York, USA, Oct. 11, 2022 (GLOBE NEWSWIRE) -- *The Global Cardiovascular Ultrasound System Market to Accelerate Substantially at a Paltry CAGR of 4.79% During the Forecast Period (2022–2027) | DelveInsight*

*The cardiovascular ultrasound system market is expected to show positive growth due to several factors, including an increase in the geriatric population, an increase in the incidence of cardiovascular diseases, an increase in sedentary lifestyles, and an increase in regulatory approvals for the cardiovascular ultrasound system. *

DelveInsight’s *Cardiovascular Ultrasound System Market Insights* report provides the current and forecast market, forthcoming device innovation, individual leading companies’ market shares, challenges, cardiovascular ultrasound system market drivers, barriers, and trends, and key cardiovascular ultrasound system companies in the market. 

*Key Takeaways from the Cardiovascular Ultrasound System Market Report*

· As per DelveInsight estimates, North America is anticipated to dominate the global cardiovascular ultrasound system market during the forecast period. 
· Notable cardiovascular ultrasound system companies such as *Koninklijke Philips N.V., Hitachi Ltd, Siemens Healthcare GmbH, CANON MEDICAL SYSTEMS CORPORATION, General Electric Company, ESAOTE SPA, SAMSUNGHEALTHCARE, Shenzhen Mindray Bio-Medical Electronics Co Ltd, FUJIFILM Healthcare Europe, Whale Imaging, Trivitron Healthcare, ATYS MEDICAL, Boston Scientific Corporation, CHISON Medical Technologies Co. Ltd, Narang Medical Limited, Clarius, Dawei Medical, FUJIFILM Sonosite Inc, Vave Health Inc*, and several others are currently operating in the cardiovascular ultrasound system market.
· In *February 2022, Philips,* a global leader in health technology, announced the FDA clearance for the United States and the launch of its point-of-care hand-held ultrasound for cardiovascular and other applications.
· In *September 2021, Samsung Medison,* a global medical equipment company and an affiliate of Samsung Electronics, introduced V8, a brand new, high-end ultrasound system that offers improved image quality, usability, and convenience for all medical professionals. The advanced functions from premium ultrasound systems dedicated to specific departments such as obstetrics, radiology, orthopedics, and cardiology have been implemented.
· In *May 2020, Royal Philips,* a global leader in health technology, announced that it had received 510(k) clearance from the U.S. Food and Drug Administration (FDA) to market a wide variety of its ultrasound solutions for the treatment of COVID-19-related lung and cardiac complications.
· In *June 2019, Esaote, *a leader in the biomedical equipment sector, launched MyLab™X7 compact console system, a new cardiovascular ultrasound line in Portland; it is a high-end portable system that offers advanced cutting-edge clinical tools, optimized image quality, an effortless workflow, and improved ergonomics for better, quicker, and more reliable decisions.

To read more about the latest highlights related to the cardiovascular ultrasound system market, get a snapshot of the key highlights entailed in the *Global **Cardiovascular Ultrasound System Market Report* 

*Cardiovascular Ultrasound System Overview*

Cardiovascular ultrasounds, also known as echocardiograms, use ultrasound imaging to create an image of the heart. It is non-invasive and aids in diagnosing and managing potentially fatal cardiovascular diseases such as heart attack, congenital heart disease, coronary artery disease, and others.

Cardiovascular ultrasonography is a painless diagnostic that uses sound waves to create moving images of the heart. Cardiovascular ultrasonography is another name for echocardiography. It can help detect blood clots in the heart. Furthermore, the cardiovascular ultrasonography system evaluates the health of the heart muscle. The three types of cardiovascular ultrasonography currently available are transthoracic echocardiography, transesophageal echocardiogram, and stress echocardiogram.

*Cardiovascular Ultrasound System Market Insights*

North America is expected to dominate the global cardiovascular ultrasound system market in 2021 and will continue to do so during the forecast period of 2022–2027. Factors such as an increase in sedentary lifestyles and rising regulatory approvals for cardiovascular ultrasound systems are expected to drive demand for cardiovascular ultrasound systems in North America.

Furthermore, rising regulatory approvals for cardiovascular ultrasound systems, combined with an increase in the prevalence of cardiac disease in the North American region, can boost demand for cardiovascular ultrasound systems, boosting the overall North American ultrasound cardiovascular system market.

For instance, Philips, a global leader in health technology, announced the FDA clearance and launch of its point-of-care hand-held ultrasound for cardiovascular and other applications in February 2022. The Lumify handheld ultrasound system now includes a Pulse Wave Doppler, which can measure blood flow in cardiology and other applications.

As a result of the interaction of all of the factors as mentioned above, ultrasound cardiovascular system demand will rise, creating a favorable growth environment for the North American region in the cardiovascular ultrasound system market.

To know more about why North America is leading the market growth in the cardiovascular ultrasound system market, get a snapshot of the *Cardiovascular Ultrasound System Market Trends*

*Cardiovascular Ultrasound System Market Dynamics*

The *growing geriatric population* suffering from cardiovascular disease is one of the primary drivers of the cardiovascular ultrasound system market. Moreover, an *increase in sedentary lifestyles and an increase in regulatory approvals *are also contributing to the growth of the cardiovascular ultrasound system market. 

However, the *high cost of the cardiovascular ultrasound system* and the *scarcity of trained professionals* to operate the cardiovascular ultrasound system may limit the global cardiovascular ultrasound system market growth.

The COVID-19 pandemic has significantly impacted the cardiovascular ultrasound system market because hospital admissions were limited due to lockdown restrictions, a lack of staff, and the postponement of various diagnosis and treatment procedures. COVID-19 also increased the level of stress in people, which can result in high blood pressure or hypertension, which can lead to heart attack or heart failure. As a result of the COVID pandemic, the cardiovascular ultrasound systems market has been significantly impacted as the device used to diagnose cardiovascular diseases in COVID patients.

However, with the mass vaccination of the population, the relaxation of lockdowns, the resumption of hospital visits, and the availability of staff for performing diagnosis procedures, the cardiovascular ultrasound system market has regained momentum and is expected to grow further during the forecast period.

Get a sneak peek at the cardiovascular ultrasound system market dynamics @*Cardiovascular Ultrasound System Market Dynamics Analysis*

*Report Metrics * *Details*
Coverage Global
Study Period 2019–2027
Market Size in 2021 USD 1.61 Billion
Projected Market Size by 2027 USD 2.11 Billion
Market CAGR 4.79%
Key Cardiovascular Ultrasound System Companies Koninklijke Philips N.V., Hitachi Ltd, Siemens Healthcare GmbH, CANON MEDICAL SYSTEMS CORPORATION, General Electric Company, ESAOTE SPA, SAMSUNGHEALTHCARE,  Shenzhen Mindray Bio-Medical Electronics Co Ltd, FUJIFILM Healthcare Europe, Whale Imaging, Trivitron Healthcare, ATYS MEDICAL, Boston Scientific Corporation, CHISON Medical Technologies Co. Ltd, Narang Medical Limited, Clarius, Dawei Medical, FUJIFILM Sonosite Inc, Vave Health Inc, among others

*Cardiovascular Ultrasound System Market Segmentation*

· *Market Segmentation By Product Type: *Cart/Trolley Based and Compact/Handheld Ultrasound Devices
· *Market Segmentation By Technology: *2D-Ultrasound, 3D-Ultrasound, 4D-Ultrasound, and Doppler
· *Market Segmentation By Display: *Color Cardiovascular Ultrasound System and Black & White Cardiovascular Ultrasound System
· *Market Segmentation By End User: *Hospital, Cardiology Centres, Ambulatory Surgical Centers, and Others
· *Market Segmentation By Geography*: North America, Europe, Asia-Pacific, and Rest of World
· *Porter’s Five Forces Analysis, Product Profiles, **Case Studies, KOL’s Views, Analyst’s View*

Which MedTech key players in the cardiovascular ultrasound system market are set to emerge as the trendsetter explore @*Cardiovascular Ultrasound System Companies** *

*Table of Contents *

1 Report Introduction
2 Executive summary
3 Regulatory and Patent Analysis
4 Key Factors Analysis
5 Porter’s Five Forces Analysis
6 COVID-19 Impact Analysis on Cardiovascular Ultrasound System Market
7 Cardiovascular Ultrasound System Market Layout
8 Global Company Share Analysis – Key 3-5 Companies
9 Cardiovascular Ultrasound System Market Company and Product Profiles
10 Project Approach
11 About DelveInsight

Interested in knowing the cardiovascular ultrasound system market by 2027? Click to get a snapshot of the *Cardiovascular Ultrasound System Market Research*

*Related Reports*

*Intracardiac Echocardiography Devices Market*

*Intracardiac Echocardiography Devices** Market Insight, Competitive Landscape, and Market Forecast – 2027 *report delivers an in-depth understanding of the market trends, market drivers, market barriers, and key intracardiac echocardiography devices companies, including *Medtronic, Infraredx, Inc., Stryker,* among others.

*Cardiac Arrhythmia Monitoring Devices Market*

*Cardiac Arrhythmia Monitoring Devices** Market Insight, Competitive Landscape, and Market Forecast – 2027 *report delivers an in-depth understanding of market trends, market drivers, market barriers, and key cardiac arrhythmia monitoring devices companies, including *Abbott Laboratories, Boston Scientific Corporation, Avanos Medical,* among others.

*Cardiac Resynchronization (CRT) Therapy Market*

*Cardiac Resynchronization (CRT) Therapy** Market Insight, Competitive Landscape, and Market Forecast – 2027 *report delivers an in-depth understanding of market trends, market drivers, market barriers, and key cardiac resynchronization (CRT) therapy companies, including *Abbott, Medtronic, Boston Scientific Corporation, BIOTRONIK,* among others.

*Implantable Cardiac Monitors (ICM) Market*

*Implantable Cardiac Monitors (ICM)** Market Insight, Competitive Landscape, and Market Forecast – 2027 *report delivers an in-depth understanding of market trends, market drivers, market barriers, and key implantable cardiac monitors (ICM) companies, including *Abbott Laboratories, Boston Scientific Corporation, Biotronik SE & Co. KG,* among others.

*Cardiac Biomarkers Testing Market*

*Cardiac Biomarkers Testing** Market Insight, Competitive Landscape, and Market Forecast – 2027 *report delivers an in-depth understanding of market trends, market drivers, market barriers, and key cardiac biomarkers testing companies, including *Beckman Coulter, Inc, Siemens Healthcare GmbH, Abbott,* among others.

*Ultrasound Devices Market*

*Ultrasound Devices Market Insight, Competitive Landscape, and Market Forecast – 2027 *report delivers an in-depth understanding of market trends, market drivers, market barriers, and key ultrasound devices companies, including *General Electric Company, FUJIFILM Sonosite Inc., Siemens Healthcare GmbH, Koninklijke Philips N.V.,* among others.

*Other Trending Reports*

*Goitre Market** |  **Thymus Cancer Market** | **US Healthcare Outlook Report** | **Venous Stenosis Market** | **Negative Pressure Wound Therapy Systems Market** | **Global Kinase Inhibitor in Autoimmune Diseases Market** | **Metrorrhagia Market** | **Dysfunctional Uterine Bleeding Market** | **Hypereosinophilic Syndrome Market** | **Age-related Vision Dysfunction Market** | **Dental Lasers Market** | **CRISPR Therapies Pipeline Insight** | **Cell And Gene Therapy For Multiple Myeloma Market** | **Drug Hypersensitivity Market** | **Dysthymia Market** | **Persistent Depressive Disorder Market** | **Cancer Vaccines Market** | **Severe Acute Respiratory Syndrome (SARS) Coronavirus Infection Market** |* *Substance use disorder Market* | *Idiopathic Thrombocytopenic Purpura Market* | *Spinal Fusion Devices Market* | *Atherectomy Devices Market* | *Prosthetic Heart Valve Market* | *Cardiac Monitoring System Market* | *Chemotherapy-induced nausea and vomiting (CINV) Market* | *Diabetes Market* | *Ocular Melanoma Market* | *Breast Pumps Market** |* *Stereotactic Surgery Devices Market*  *Atopic Dermatitis Market* | *Concussions Market* | *Osteoporosis Market* | *Myelofibrosis (MF) Market* | *Cancer Cachexia (CC) Market*

*Related Healthcare Blogs*

*Upcoming Cardiovascular Diseases Drugs*

*Key Companies in the Cardiology Segment*

*Heart Failure Market*

*Top Cardiac Devices in the Market*

*About DelveInsight*

DelveInsight is a leading Business Consultant, and Market Research firm focused exclusively on life sciences. It supports pharma companies by providing comprehensive end-to-end solutions to improve their performance.  

CONTACT: Contact Us

Shruti Thakur 

info@delveinsight.com 

+1(919)321-6187 

https://www.delveinsight.com/medical-devices